DataSheet2_Mechanistic PK-PD model of alendronate treatment of postmenopausal osteoporosis predicts bone site-specific response.ZIP by José L. Calvo-Gallego (13258440)

“…We identified that this BDG is mainly due to an increase in tissue mineralization and a decrease in porosity. The difference in BDG between sites is linked to the different loading and dependence of the released alendronate on the bone-specific surface and porosity. …”

DataSheet1_Mechanistic PK-PD model of alendronate treatment of postmenopausal osteoporosis predicts bone site-specific response.pdf by José L. Calvo-Gallego (13258440)

“…We identified that this BDG is mainly due to an increase in tissue mineralization and a decrease in porosity. The difference in BDG between sites is linked to the different loading and dependence of the released alendronate on the bone-specific surface and porosity. …”

Characterizing repeats at k-mer level. by Shahab Sarmashghi (6332315)

“…The results are 5% p-value = 1.1 × 10⁻⁶, 10% p-value = 4.3 × 10⁻⁶, and 10% p-value = 4.2 × 10⁻⁶ when comparing plants against invertebrates, mammals, and other vertebrates, respectively. …”

Plant species loss reduces rare soil microbes through diversity effect amplified by multitrophic interactions by Jie Li (14726914)

Image_3_CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma Microenvironment.TIF by Yinjiang Zhang (5030006)

“…Also, hsa-miR-4278 and hsa-miR-324-5p, two potential miRNA targets of CLEC4s, were uncovered. …”

Table_1_Impact of Computed Tomography-Based, Artificial Intelligence-Driven Volumetric Sarcopenia on Survival Outcomes in Early Cervical Cancer.docx by Qingling Han (11477659)

“…During primary treatment, significant decreases in waist skeletal muscle (median, −3.9%; p < 0.001) and total fat (median, −5.3%; p < 0.001) were observed. …”

Table_3_Impact of Computed Tomography-Based, Artificial Intelligence-Driven Volumetric Sarcopenia on Survival Outcomes in Early Cervical Cancer.docx by Qingling Han (11477659)

“…During primary treatment, significant decreases in waist skeletal muscle (median, −3.9%; p < 0.001) and total fat (median, −5.3%; p < 0.001) were observed. …”

Table_2_Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis.xlsx by Jianfeng Shu (12518655)

“…Background<p>Lung adenocarcinoma (LUAD) as a frequent type of lung cancer has a 5-year overall survival rate of lower than 20% among patients with advanced lung cancer. …”

Image_3_Impact of Computed Tomography-Based, Artificial Intelligence-Driven Volumetric Sarcopenia on Survival Outcomes in Early Cervical Cancer.tif by Qingling Han (11477659)

“…During primary treatment, significant decreases in waist skeletal muscle (median, −3.9%; p < 0.001) and total fat (median, −5.3%; p < 0.001) were observed. …”

Table_7_Impact of Computed Tomography-Based, Artificial Intelligence-Driven Volumetric Sarcopenia on Survival Outcomes in Early Cervical Cancer.docx by Qingling Han (11477659)

“…During primary treatment, significant decreases in waist skeletal muscle (median, −3.9%; p < 0.001) and total fat (median, −5.3%; p < 0.001) were observed. …”

Image_1_CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma Microenvironment.TIF by Yinjiang Zhang (5030006)

“…Also, hsa-miR-4278 and hsa-miR-324-5p, two potential miRNA targets of CLEC4s, were uncovered. …”

DataSheet_3_Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis.pdf by Jianfeng Shu (12518655)

“…Background<p>Lung adenocarcinoma (LUAD) as a frequent type of lung cancer has a 5-year overall survival rate of lower than 20% among patients with advanced lung cancer. …”

Table_1_Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis.xlsx by Jianfeng Shu (12518655)

“…Background<p>Lung adenocarcinoma (LUAD) as a frequent type of lung cancer has a 5-year overall survival rate of lower than 20% among patients with advanced lung cancer. …”

Image_1_Impact of Computed Tomography-Based, Artificial Intelligence-Driven Volumetric Sarcopenia on Survival Outcomes in Early Cervical Cancer.tif by Qingling Han (11477659)

“…During primary treatment, significant decreases in waist skeletal muscle (median, −3.9%; p < 0.001) and total fat (median, −5.3%; p < 0.001) were observed. …”

Image_9_CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma Microenvironment.TIF by Yinjiang Zhang (5030006)

“…Also, hsa-miR-4278 and hsa-miR-324-5p, two potential miRNA targets of CLEC4s, were uncovered. …”

Data_Sheet_1_The pattern from the first three rounds of vaccination: declining vaccination rates.docx by Jian Wu (41301)

“…</p>Results<p>A total of 957 participants with chronic disease and 5,454 participants without chronic disease were included in this survey. …”

Image_4_Impact of Computed Tomography-Based, Artificial Intelligence-Driven Volumetric Sarcopenia on Survival Outcomes in Early Cervical Cancer.tif by Qingling Han (11477659)

“…During primary treatment, significant decreases in waist skeletal muscle (median, −3.9%; p < 0.001) and total fat (median, −5.3%; p < 0.001) were observed. …”

Table_6_Impact of Computed Tomography-Based, Artificial Intelligence-Driven Volumetric Sarcopenia on Survival Outcomes in Early Cervical Cancer.docx by Qingling Han (11477659)

“…During primary treatment, significant decreases in waist skeletal muscle (median, −3.9%; p < 0.001) and total fat (median, −5.3%; p < 0.001) were observed. …”

Image_7_CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma Microenvironment.TIF by Yinjiang Zhang (5030006)

“…Also, hsa-miR-4278 and hsa-miR-324-5p, two potential miRNA targets of CLEC4s, were uncovered. …”

Table_3_Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis.xlsx by Jianfeng Shu (12518655)

“…Background<p>Lung adenocarcinoma (LUAD) as a frequent type of lung cancer has a 5-year overall survival rate of lower than 20% among patients with advanced lung cancer. …”